No Drug In Two Products Being Sold In Market

Warangal : The Hanumakonda district drug inspector J Kiran Kumar said in a press release that they have identified two drugs that contained no active pharmaceutical ingredients in the local market of Kakaji Colony in Hanumakonda.

According to the drug inspector, the drug content is nil in the Pan-D capsules (Batch No. 22441755) and Pan 40 (Batch N. 22442076) tablets. These drugs are used in the treatment of ulcer and acidity, he added.

These drugs were manufactured by a reputed company in India. The local agencies procured these drugs through online order from Bangalore-based Saveo Healthtech. The local pharma agencies received these stocks from Aminabad, Lucknow (UP). The government drug analysts confirmed that both the medicines contained ‘nil drug’, Kiran Kumar said. Following which the drug officials have sent notices to the company and distributors.

Meanwhile, the drug inspector instructed the druggists and chemists not to purchase drugs online, and without a valid invoice. The drug inspector also directed them to report him if they find any suspicious drugs. He urged the customers to check the above mentioned batch numbers before they purchase Pan-D capsules or Pan 40 tablets.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’